FLT3LG
Fms-related tyrosine kinase 3 ligand
Also known as: FLT3L_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P49771
- Gene
- FLT3LG
- Ensembl
- ENSG00000090554
- Chromosome
- 19
- Canonical length
- 235 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins
- Secretome location
- Secreted to blood
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Dendritic cells (DCs) provide the key link between innate and adaptive immunity by recognizing pathogens and priming pathogen-specific immune responses. FLT3LG controls the development of DCs and is particularly important for plasmacytoid DCs and CD8 (see MIM 186910)-positive classical DCs and their CD103 (ITGAE; MIM 604682)-positive tissue counterparts (summary by Sathaliyawala et al., 2010 [PubMed 20933441]).[supplied by OMIM, Jan 2011]
Canonical amino-acid sequenceUniProt
235 residues, UniProt reviewed canonical sequence.
>P49771|FLT3LG
1 MTVLAPAWSP TTYLLLLLLL SSGLSGTQDC SFQHSPISSD FAVKIRELSD YLLQDYPVTV
61 ASNLQDEELC GGLWRLVLAQ RWMERLKTVA GSKMQGLLER VNTEIHFVTK CAFQPPPSCL
121 RFVQTNISRL LQETSEQLVA LKPWITRQNF SRCLELQCQP DSSTLPPPWS PRPLEATAPT
181 APQPPLLLLL LLPVGLLLLA AAWCLHWQRT RRRTPRPGEQ VPPVPSPQDL LLVEHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FLT3LG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- vagina: 23 nTPM
- lymph node: 23 nTPM
- cervix: 23 nTPM
- thymus: 21 nTPM
- colon: 20 nTPM
- adipose tissue: 20 nTPM
Single-cell type
- decidual stromal cells: 26 nCPM
- t-cells: 23 nCPM
- oocytes: 14 nCPM
- innate lymphoid cells: 10 nCPM
- leydig cells: 9 nCPM
- fibroblasts: 8.7 nCPM
Immune cell
- T-reg: 172 nTPM
- naive CD4 T-cell: 170 nTPM
- memory CD4 T-cell: 159 nTPM
- MAIT T-cell: 145 nTPM
- naive CD8 T-cell: 138 nTPM
- memory CD8 T-cell: 102 nTPM
Brain region
- medulla oblongata: 15 nTPM
- pons: 13 nTPM
- white matter: 12 nTPM
- thalamus: 12 nTPM
- basal ganglia: 12 nTPM
- choroid plexus: 12 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FLT3LG.
Disease | AllUniProt
Conditions FLT3LG is implicated in, by any mechanism.
- Immunodeficiency 125 (IMD125) MIM:620926
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 45 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Immunodeficiency 125
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.36
- gnomAD pLI
- 0.94
- gnomAD missense Z
- 0.9
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- B cell differentiation
- dendritic cell differentiation
- embryonic hemopoiesis
- positive regulation of cell population proliferation
- positive regulation of natural killer cell proliferation
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Four-helical cytokine-like, core
- Flt3 ligand
- flt3 ligand
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FLT3LG as an antibody target. Whether an autoantibody or antibody against FLT3LG could matter depends on whether native FLT3LG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FLT3LG is annotated at the cell surface, where native FLT3LG is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label FLT3LG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...